Literature DB >> 29596901

Periaqueductal gray glutamatergic, cannabinoid and vanilloid receptor interplay in defensive behavior and aversive memory formation.

Franklin P Back1, Antonio P Carobrez2.   

Abstract

Stimulation of the midbrain periaqueductal gray matter (PAG) in humans elicits sensations of fear and impending terror, and mediates predator defensive responses in rodents. In rats, pharmacological stimulation of the dorsolateral portion of the PAG (dlPAG) with N-Methyl-d-Aspartate (NMDA) induces aversive conditioning that acts as an unconditioned stimulus (US). In the present work, we investigated the interplay between the vanilloid TRPV1 and cannabinoid CB1 receptors in the NMDA-dlPAG defensive response and in subsequent aversive learning. Rats were subjected to dlPAG NMDA infusion in an olfactory conditioned stimulus (CS) task allowing the evaluation of immediate and long-term defensive behavioral responses during CS presentation. The results indicated that an intermediate dose of NMDA (50 pmol) induced both immediate and long-term effects. A sub-effective dose of NMDA (25 pmol) was potentiated by the TRPV1 receptor agonist capsaicin (CAP, 1 nmol) and the CB1 receptor antagonist, AM251 (200 pmol). CAP (10 nmol) or the combination of CAP (1 nmol) and AM251 (200 pmol) induced long-term effects without increasing immediate defensive responses. The glutamate release inhibitor riluzole (2 or 4 nmol) and the AMPA/kainate receptor antagonist DNQX (2 or 4 nmol) potentiated the immediate effects but blocked the long-term effects. The results showed that immediate defensive responses rely on NMDA receptors, and aversive learning on the fine-tuning of TRPV1, CB1, metabotropic glutamate and AMPA receptors located in pre- and postsynaptic membranes. In conclusion, the activity of the dlPAG determines core affective aspects of aversive memory formation controlled by local TRPV1/CB1 balance.
Copyright © 2018 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  AMPA receptors; Aversive memory formation; CB1 receptors; NMDA receptors; Olfactory fear conditioning; TRPV1 receptors

Mesh:

Substances:

Year:  2018        PMID: 29596901     DOI: 10.1016/j.neuropharm.2018.03.032

Source DB:  PubMed          Journal:  Neuropharmacology        ISSN: 0028-3908            Impact factor:   5.250


  9 in total

1.  Distribution and Assembly of TRP Ion Channels.

Authors:  Wei Cheng; Jie Zheng
Journal:  Adv Exp Med Biol       Date:  2021       Impact factor: 2.622

2.  A Neural Circuit for Spirituality and Religiosity Derived From Patients With Brain Lesions.

Authors:  Michael A Ferguson; Frederic L W V J Schaper; Alexander Cohen; Shan Siddiqi; Sarah M Merrill; Jared A Nielsen; Jordan Grafman; Cosimo Urgesi; Franco Fabbro; Michael D Fox
Journal:  Biol Psychiatry       Date:  2021-06-29       Impact factor: 13.382

Review 3.  The role of endocannabinoids in consolidation, retrieval, reconsolidation, and extinction of fear memory.

Authors:  Ikumi Mizuno; Shingo Matsuda
Journal:  Pharmacol Rep       Date:  2021-05-06       Impact factor: 3.024

Review 4.  Cannabinoid Control of Olfactory Processes: The Where Matters.

Authors:  Geoffrey Terral; Giovanni Marsicano; Pedro Grandes; Edgar Soria-Gómez
Journal:  Genes (Basel)       Date:  2020-04-16       Impact factor: 4.096

Review 5.  Role of the dorsal periaqueductal gray in posttraumatic stress disorder: mediation by dopamine and neurokinin.

Authors:  M L Brandão; T A Lovick
Journal:  Transl Psychiatry       Date:  2019-09-17       Impact factor: 6.222

6.  Functional activation of the periaqueductal gray matter during conditioned and unconditioned fear in guinea pigs confronted with the Boa constrictor constrictor snake.

Authors:  B B de Paula; E B Vieira-Rasteli; F Calvo; N C Coimbra; C R A Leite-Panissi
Journal:  Braz J Med Biol Res       Date:  2022-02-16       Impact factor: 2.590

Review 7.  TRPV1: A Common Denominator Mediating Antinociceptive and Antiemetic Effects of Cannabinoids.

Authors:  Kathleen Louis-Gray; Srinivasan Tupal; Louis S Premkumar
Journal:  Int J Mol Sci       Date:  2022-09-02       Impact factor: 6.208

Review 8.  The neuropsychopharmacology of cannabis: A review of human imaging studies.

Authors:  Michael A P Bloomfield; Chandni Hindocha; Sebastian F Green; Matthew B Wall; Rachel Lees; Katherine Petrilli; Harry Costello; M Olabisi Ogunbiyi; Matthijs G Bossong; Tom P Freeman
Journal:  Pharmacol Ther       Date:  2018-10-19       Impact factor: 12.310

Review 9.  The Construct of Medical and Non-Medical Marijuana-Critical Review.

Authors:  Andrzej Silczuk; Daria Smułek; Marcin Kołodziej; Julia Gujska
Journal:  Int J Environ Res Public Health       Date:  2022-02-27       Impact factor: 3.390

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.